Patent · US Expired

Compositions for the control of hyperlipidemia

US5034528A · kind A · utility

7Cited by
6References
4Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 27, 1988
Grant dateJul 23, 1991
Priority date
Expiry dateJul 27, 2008

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/53
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides pharmaceutical compositions comprising hypolipidemically active derivatives of 1,2,4-triazolidine-3,5-diones, 1,3,5-triazabicyclo[3.1.0]hexane-2,4-diones, and 1,3,5-triazine-2,4(1H,3H)-diones in a pharmaceutically acceptable carrier for treating hyperlipidemia in mammals, particularly humans.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.